This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Apr;3(2):174-175.

doi: 10.1016/j.euo.2020.02.008. Epub 2020 Mar 20.

Primum Non Nocere: When Nephrectomy Becomes a Selective Approach in Metastatic Renal Cell Carcinoma

Arnaud Méjean¹

Affiliations

PMID: 32201134
DOI: 10.1016/j.euo.2020.02.008

Editorial

Primum Non Nocere: When Nephrectomy Becomes a Selective Approach in Metastatic Renal Cell Carcinoma

Arnaud Méjean. Eur Urol Oncol. 2020 Apr.

. 2020 Apr;3(2):174-175.

doi: 10.1016/j.euo.2020.02.008. Epub 2020 Mar 20.

Author

Arnaud Méjean¹

Affiliation

¹ Department of Urology, APHP, Université de Paris, Paris, France. Electronic address: arnaud.mejean@aphp.fr.

PMID: 32201134
DOI: 10.1016/j.euo.2020.02.008

No abstract available

PubMed Disclaimer

Comment on

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.
de Bruijn R, Wimalasingham A, Szabados B, Stewart GD, Welsh SJ, Kuusk T, Blank C, Haanen J, Klatte T, Staehler M, Powles T, Bex A. de Bruijn R, et al. Eur Urol Oncol. 2020 Apr;3(2):168-173. doi: 10.1016/j.euo.2019.12.004. Epub 2020 Jan 16. Eur Urol Oncol. 2020. PMID: 31956080

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information